Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookUganda Pharmaceutical Sector Baseline Survey (HAI, WHO; 2002; 67 pages)
View the documentForeword
View the documentAcknowledgments
View the documentAbbreviations
View the documentExecutive summary
close this folder1. Introduction
View the documenta) Demographic characteristics
View the documentb) Health characteristics
View the documentc) Health policy
View the documentd) Health system structure
close this foldere) The Pharmaceutical Sector
View the documenti) National Drug Policy
View the documentii) Drug supply system
View the documentiii) Key pharmaceutical indicators
View the documentiv) Pharmaceutical sector surveys
Open this folder and view contents2. Study Design and Methodology
Open this folder and view contents3. Findings
View the document4. Interpretation of Results
Open this folder and view contents5. Conclusions and Recommendations
Open this folder and view contentsANNEXES
 

i) National Drug Policy

Overall goal

The revised National Drug Policy (NDP) 2001 aims to contribute to the attainment of a good standard of health by the population of Uganda, through ensuring the availability, accessibility and affordability at all times of essential drugs of appropriate quality, safety and efficacy, and by promoting their rational use.

Main objectives

• To make essential drugs accessible to all those who need them by ensuring that they are affordable and always available in all parts of the country.

• To ensure that all drugs available to the public are of appropriate quality, safety, and efficacy.

• To promote the rational use of drugs actively and continuously and to provide objective, relevant and practical information to health workers, patients and the general public.

• To institute and sustain suitable drug financing mechanisms which will ensure the continuous availability of adequate quantities of the required essential drugs.

• To ensure the availability of sufficient suitably trained pharmaceutical and other relevant staff to enable effective implementation of NDP.

• To optimise use of available resources, knowledge and expertise in implementation of NDP through the establishment of an active partnership between the community, government bodies and private providers (profit and non-profit) involved in the pharmaceutical sector and through cooperation with regional and international agencies.

to previous sectionto next section

Please provide your feedback
Abbreviations
English  |  French